Anti-EMA CE/IVD for IHC - Hematopathology

Anti-EMA CE/IVD for IHC - Hematopathology

Epithelial membrane antigen (EMA), corresponding to MUC1, is a high-molecular-weight, heavily glycosylated transmembrane mucin expressed on the apical surface of many epithelial cells. Its structural and functional properties have been extensively characterized in peer-reviewed literature, supporting roles in cell adhesion, intracellular signaling, and epithelial organization.

Biological Significance of EMA (MUC1)

  • EMA/MUC1 is a type I transmembrane glycoprotein characterized by extensive O-linked glycosylation, which contributes to its antigenic and structural properties.
  • It participates in modulation of cell–cell and cell–matrix interactions, as well as intracellular signaling pathways.
  • In normal epithelial tissues, MUC1 is typically apically polarized, whereas in malignant transformation it often shows loss of polarity, overexpression, and altered glycosylation.
  • Aberrant glycosylation patterns are associated with tumor-associated phenotypes and changes in cellular behavior.

Diagnostic Utility in Hematopathology

  • EMA is commonly used in immunohistochemistry (IHC) panels as a marker to support identification of epithelial differentiation in the evaluation of neoplasms.
  • It can assist in distinguishing carcinomas from many hematolymphoid and mesenchymal tumors, but it is not entirely specific.
  • EMA expression may be observed in certain hematopoietic neoplasms, including plasma cell neoplasms (e.g., plasmacytoma) and in subsets of lymphomas, where it can support diagnostic interpretation.
  • In practice, EMA is interpreted alongside other markers in a broader panel, particularly in cases of poorly differentiated malignancies, to help determine lineage when morphology is inconclusive.

Key Features of EMA CE/IVD Antibodies

  • Intended for in vitro diagnostic (IVD) use when appropriately validated within regulated laboratory workflows; CE marking indicates conformity with applicable regulatory requirements in relevant jurisdictions (product- and manufacturer-dependent).
  • Optimized for detection in formalin-fixed, paraffin-embedded (FFPE) tissues, supporting routine histopathology workflows.
  • Designed to produce membranous and/or cytoplasmic staining patterns, consistent with the known subcellular localization of MUC1/EMA in tissue sections.
  • Performance characteristics such as sensitivity, specificity, and reproducibility depend on validated protocols, including antigen retrieval conditions, antibody clone, detection system, and laboratory quality controls.
 
 
Breast carcinoma section
Stomach cancer section

 

Search result : 6 product found

Refine your search :

RUO
CE/IVD
NEW
  • Unconjugated 6
  • human 6
  • mouse 6
  • Primary antibody
  • IHC 6
  • IHC566 3
  • IHC623 3
APPLY FILTERS
REINITIALIZE


Cat#
Description
Cond.
Price Bef. VAT
IHC566-100
 0.1ml,Concentrated